Breaking News Instant updates and real-time market news.

PLNT

Planet Fitness

$75.57

-3.1 (-3.94%)

, WMT

Walmart

$99.89

-2.02 (-1.98%)

09:37
05/14/19
05/14
09:37
05/14/19
09:37

Tariffs to yield major EPS cuts, higher customer prices, says Cowen

Amid the U.S./China trade battle, Cowen analyst Oliver Chen says negative EPS impact could be (10%-(30%) or worse as retailers are unlikely to be able to pass on all of potential cost of goods sold increases. The analyst believes the best positioned Outperform rated stocks are Planet Fitness (PLNT), Walmart (WMT), Ulta Beauty (ULTA), LVMH (LVMUY), and Costco (COST) as these have lower China sourcing risk and greater scale. He sees the most potential vulnerability at apparel and department store retailers. Further, Chen believes that consumers could experience price increases by as much as 10%-15% across impacted categories, which would yield up to $100B or more of incremental cost to consumers, depending on the breadth and depth of goods impacted. These factors are likely to impact supply/demand planning for back to school and holiday, he contends.

PLNT

Planet Fitness

$75.57

-3.1 (-3.94%)

WMT

Walmart

$99.89

-2.02 (-1.98%)

ULTA

Ulta Beauty

$330.37

-12.98 (-3.78%)

LVMUY

LVMH

$0.00

(0.00%)

COST

Costco

$242.00

-5.06 (-2.05%)

  • 14

    May

  • 16

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 05

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 07

    Jun

  • 13

    Nov

PLNT Planet Fitness
$75.57

-3.1 (-3.94%)

05/07/19
MACQ
05/07/19
UPGRADE
MACQ
Outperform
Planet Fitness upgraded to Outperform from Neutral at Macquarie
04/29/19
COWN
04/29/19
NO CHANGE
Target $85
COWN
Outperform
Planet Fitness price target raised to $85 from $65 at Cowen
Cowen analyst Oliver Chen acknowledged that expectations are high for Planet Fitness with the stock up 42% year-to-date, but he believes the stock should trade near a high-growth peer average multiple given its strong fundamentals. The firm's consumer tracker indicates continuous improvement in membership growth and Chen sees Planet being well positioned for a solid quarter and to raise guidance modestly. Ahead of earnings, the analyst raised his price target on Planet Fitness shares to $85 from $65 and reiterated his Outperform rating.
05/03/19
JEFF
05/03/19
NO CHANGE
Target $85
JEFF
Buy
Planet Fitness price target raised to $85 from $75 at Jefferies
Jefferies analyst Randal Konik raised his price target for Planet Fitness (PLNT) to $85 from $75 saying the company reported "great" Q1 results with comps and margins ahead of consensus. However, the shares are trading lower due to elevated expectations, Konik tells investors in a research note. He continues to believe Planet Fitness' investments in marketing, expanding affinity programs, increasing Black Card penetration, and membership growth resemble a business model similar to that of Amazon.com (AMZN). The analyst sees upside in the shares and reiterates a Buy rating on the name.
05/03/19
PIPR
05/03/19
NO CHANGE
Target $84
PIPR
Overweight
Planet Fitness earnings selloff a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Peter Keith recommends buying shares of Planet Fitness on today's post-earnings selloff. Comp growth remained 10% and margins saw nice expansion, Keith tells investors in a research note. The analyst views the maintained annual guidance as conservative and reiterates an Overweight rating on the shares with an $84 price target. He continues to see ~30% earnings growth for Planet Fitness thought at least 2020.
WMT Walmart
$99.89

-2.02 (-1.98%)

05/03/19
05/03/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Domtar (UFS) upgraded to Buy from Neutral at Goldman Sachs with analyst Brian Maguire saying the current valuation on the stock marks an attractive entry point. 2. Kirby (KEX) upgraded to Buy from Underperform at BofA/Merrill with analyst Ken Hoexter stating shares have been under pressure due to overcapacity in the barging market. 3. Walmart (WMT) upgraded to Outperform from Market Perform at Bernstein with analyst Brandon Fletcher saying that while he thinks Walmart has not been able to return to its full potential for decades, the fully realized vision of what Walmart could be is "so fantastic that, if it even accidentally leans in the right direction," it could create an outsized investment return over several years. 4. Seagate (STX) upgraded to Buy from Hold at Argus with analyst Jim Kelleher stating the company looks to be "closer" to the end of the downturn in its end markets and he expects its "revitalized portfolio" to be well positioned once demand recovers. 5. Tilray (TLRY) upgraded to Hold from Underperform at Jefferies with analyst Owen Bennett saying that while he remains cautious on Tilray's outlook, "this now appears to be much better appreciated by the market" at current valuation levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/09/19
LOOP
05/09/19
NO CHANGE
Target $75
LOOP
Buy
Green Dot price target lowered to $75 from $100 at Loop Capital
Loop Capital analyst Joseph Vafi lowered his price target on Green Dot (GDOT) to $75 after its FY19 profitability guidance cut, saying the company's decision to "materially" increase investment this year was "surprising." The analyst also notes that Green Dot's attractive end market opportunities and leading position justify his maintained Buy rating. Vafi adds that he was encouraged by the management's commentary indicating "increased collaboration on new products with Walmart (WMT)" ahead of its expected contract renewal with the retailer next year.
05/08/19
WOLF
05/08/19
DOWNGRADE
WOLF
Underperform
Walmart downgraded to Underperform from Peer Perform at Wolfe Research
Wolfe Research analyst Scott Mushkin downgraded Walmart to Underperform from Peer Perform.
05/03/19
RBCM
05/03/19
INITIATION
Target $39
RBCM
Outperform
Synchrony assumed with an Outperform at RBC Capital
RBC Capital analyst Jon Arfstrom assumed coverage of Synchrony (SYF) with an Outperform rating and a price target of $39, saying the company matches his criteria of "leverage to consumer strength." The analyst also believes that Synchrony's outlook remains "favorable" after its "solid" Q1 trends and expects the company to get past the "noise" around its PayPal (PYPL) partnership and Walmart (WMT) exit.
ULTA Ulta Beauty
$330.37

-12.98 (-3.78%)

04/26/19
OPCO
04/26/19
NO CHANGE
Target $400
OPCO
Outperform
Ulta Beauty price target raised to $400 from $360 at Oppenheimer
Oppenheimer analyst Rupesh Parikh tells investors in a research note that Ulta Beauty continues to rank as a top pick. After revisiting his investment thesis, he raised his price target to $400 based on valuation more consistent with historical averages and reiterated an Outperform rating. Separately, the analyst expects Ulta to deliver Q1 results consistent with consensus forecasts in an otherwise challenging U.S. beauty backdrop.
05/14/19
GUGG
05/14/19
NO CHANGE
Target $375
GUGG
Buy
Ulta Beauty price target raised to $375 from $350 at Guggenheim
Guggenheim analyst Steven Forbes raised his price target for Ulta Beauty to $375 from $350 and reiterates a Buy rating on the shares. After reviewing Euromonitor's 2019 Beauty and Personal Care report and market data, the analyst has increased confidence in Ulta's ability to meet or exceed consensus revenue estimates through 2020. Moderated market share expectations, especially within cosmetics, coupled with above-trend growth in skin care and hair care, should drive share price outperformance for Ulta Beauty in 2019, Forbes tells investors in a research note.
04/18/19
BARD
04/18/19
NO CHANGE
Target $395
BARD
Outperform
Ulta Beauty price target raised to $395 from $365 at Baird
Baird analyst Mark Altschwager raised his price target for Ulta Beauty to $395 from $365 after speaking with the company's management, telling investors in a research note that he remains encouraged by momentum behind recent brand launches, while his quarter-to-date promotional checks suggest healthy traffic levels have continued despite a generally sluggish traffic environment. He maintains an Outperform rating on the shares.
04/18/19
PIPR
04/18/19
NO CHANGE
Target $378
PIPR
Overweight
Ulta Beauty price target raised to $378 from $362 at Piper Jaffray
Piper Jaffray analyst Erinn Murphy raised her price target for Ulta Beauty to $378 from $362 following quarter-to-date channel checks and a deeper dive into Piper's teen survey data. The survey had Ulta moving to the number one spot as a preferred beauty destination, unseating Sephora for the first time, Murphy tells investors in a research note. Further, channel checks show continued newness in stores, says the analyst. She also recently noticed CBD products carried at physical Ulta locations. Murphy raised her Q1 comp estimate from 6.5% to 7.5% and earnings per share estimate from $3.00 to $3.07, a penny ahead of consensus. She keeps an Overweight rating on Ulta Beauty.
LVMUY LVMH
$0.00

(0.00%)

04/30/19
SBSH
04/30/19
INITIATION
SBSH
Buy
LVMH resumed with a Buy at Citi
Citi analyst Thomas Chauvet resumed coverage of LVMH with a Buy rating and increased price target of EUR 392 price target. The analyst believes Vuitton and Dior's popularity is intact and that the company's Chinese demand outlook is favorable.
04/11/19
SOCG
04/11/19
UPGRADE
SOCG
Buy
LVMH upgraded to Buy from Hold at Societe Generale
Societe Generale analyst Thierry Cota upgraded LVMH Moet Hennessy Louis Vuitton to Buy from Hold and raised his price target for the shares to EUR 385 from EUR 322 following yesterday's Q1 sales report.
02/06/19
JEFF
02/06/19
DOWNGRADE
JEFF
Hold
LVMH downgraded to Hold from Buy at Jefferies
Jefferies analyst Flavio Cereda downgraded LVMH Moet Hennessy Louis Vuitton to Hold with a price target of EUR 300. The shares are approaching fair value following the post-earnings rally, Cereda tells investors in a research note.
12/17/18
JEFF
12/17/18
DOWNGRADE
Target $25
JEFF
Hold
Belmond downgraded to Hold from Buy at Jefferies
Jefferies analyst David Katz downgraded Belmond (BEL) to Hold while raising his price target for the shares to $25 from $22 following LVMH's (LVMUY) acquisition proposal. The analyst believes the proposed price will be the ultimate clearing price for the transaction. He sees a low likelihood of a further unsolicited bid coming forward.
COST Costco
$242.00

-5.06 (-2.05%)

04/24/19
ROTH
04/24/19
NO CHANGE
Target $33
ROTH
Buy
Lovesac price target raised to $33 from $28 at Roth Capital
Roth Capital analyst Dave King raised his price target for Lovesac (LOVE) to $33 from $28 as he expects Q4 results to exceed expectations helped by the continuation of high-ROI national TV ads, upside from the company's expanding Costco (COST) relationship, and slower year over year growth in marketing costs. The analyst reiterates a Buy rating on Lovesac's shares as the company looks poised to "significantly disrupt the furniture industry" with patent-protected modular couches and other products that are easily shippable, customizable, sustainable, and 100% proprietary. Lovesac also looks well-positioned as a potential longer-term takeout target, he contends.
04/24/19
BARD
04/24/19
NO CHANGE
Target $270
BARD
Outperform
Costco price target raised to $270 from $250 at Baird
Baird analyst Peter Benedict raised his price target for Costco Wholesale to $270 from $250 and reiterates an Outperform rating on the shares. Increased control over product supply is an underappreciated part of the Costco investment story, Benedict tells investors in a research note. He believes the company's vertical initiatives strengthen its "already-considerable" competitive advantages in the marketplace as well as add durability to its "quality/value/limited-assortment" strategy. Ultimately these will provide "fuel for continued profitable market share gains," according to Benedict.
04/17/19
OPCO
04/17/19
NO CHANGE
Target $270
OPCO
Outperform
Costco price target raised to $270 from $245 at Oppenheimer
Oppenheimer analyst Rupesh Parikh raised his price target for Costco (COST) to $270 from $245 after spending time visiting senior management. The analyst overall walked away still constructive on Costco's prospects, and continues to believe the company remains best positioned in his entire food and grocery coverage to deliver sustainable top- and bottom-line performance. Parikh still sees the potential for a special dividend of as much as $9-plus in coming quarters. The analyst notes that Costco and Dollar General (DG) remain his top food retailing/discounter picks. He reiterates an Outperform rating on Costco's shares.
05/09/19
WELS
05/09/19
NO CHANGE
Target $240
WELS
Market Perform
Costco price target raised to $240 from $225 at Wells Fargo
Wells Fargo analyst Edward Kelly raised his price target for Costco to $240 from $225 after April sales came in above somewhat tempered expectations as the company delivered "solid" growth for the four-week April period. Overall, the analyst views the update positively as the company's core U.S. business continues to deliver "strong" top-line results even as the difficulty of comparisons has edged up. While we remain impressed by the company's clear ability to capture share, lap hard comparisons, and provide better flow through last quarter, the likelihood of a potential slowdown against a near peak valuation keeps him sidelined. Kelly reiterates a Market Perform on the shares.

TODAY'S FREE FLY STORIES

UBER

Uber

$41.40

0.94 (2.32%)

17:49
05/24/19
05/24
17:49
05/24/19
17:49
Hot Stocks
Uber board director Ryan Graves intends to resign »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

APTO

Aptose Biosciences

$2.01

0.03 (1.52%)

17:46
05/24/19
05/24
17:46
05/24/19
17:46
Syndicate
Aptose Biosciences files for $40M at-the-market common stock offering »

Piper Jaffray and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TRNX

Taronis Technologies

$0.48

0.004 (0.84%)

17:26
05/24/19
05/24
17:26
05/24/19
17:26
Syndicate
Breaking Syndicate news story on Taronis Technologies »

Taronis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:25
05/24/19
05/24
17:25
05/24/19
17:25
Hot Stocks
U.S. Energy discloses Nasdaq notice regarding delayed 10-Q filing »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

17:22
05/24/19
05/24
17:22
05/24/19
17:22
Periodicals
Apple sued over allegedly selling users' iTunes data, Bloomberg says »

Apple is being sued by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SPCB

SuperCom

$1.17

-0.005 (-0.43%)

17:21
05/24/19
05/24
17:21
05/24/19
17:21
Hot Stocks
SuperCom discloses Nasdaq notice regarding delayed 20-F filing »

SuperCom received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:20
05/24/19
05/24
17:20
05/24/19
17:20
Hot Stocks
U.S. Energy receives noncompliance notice from Nasdaq »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:18
05/24/19
05/24
17:18
05/24/19
17:18
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:17
05/24/19
05/24
17:17
05/24/19
17:17
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$87.49

3.03 (3.59%)

, QGEN

Qiagen

$38.22

-0.255 (-0.66%)

16:57
05/24/19
05/24
16:57
05/24/19
16:57
Hot Stocks
Qiagen launches diagnostic for PIK3CA biomarkers in breast cancer »

Qiagen (QGEN) announced…

NVS

Novartis

$87.49

3.03 (3.59%)

QGEN

Qiagen

$38.22

-0.255 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

  • 20

    Jun

  • 06

    Aug

AVH

Avianca

$3.96

0.91 (29.84%)

16:56
05/24/19
05/24
16:56
05/24/19
16:56
Periodicals
ANAC suspends flights, operations of Avianca Brasil, Reuters reports »

Brazil's ANAC said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

16:53
05/24/19
05/24
16:53
05/24/19
16:53
Periodicals
Apple acquires startup Tueo Health, CNBC reports »

Apple has bought Tueo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SHSP

SharpSpring

$16.37

-0.24 (-1.44%)

16:52
05/24/19
05/24
16:52
05/24/19
16:52
Syndicate
Breaking Syndicate news story on SharpSpring »

SharpSpring files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

CREG

China Recycling Energy

$0.48

0.005 (1.05%)

16:41
05/24/19
05/24
16:41
05/24/19
16:41
Syndicate
Breaking Syndicate news story on China Recycling Energy »

China Recycling Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENC

Fennec

$3.88

(0.00%)

16:36
05/24/19
05/24
16:36
05/24/19
16:36
Conference/Events
Fennec management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 18

    Jun

TD

Toronto-Dominion

$56.66

0.65 (1.16%)

16:35
05/24/19
05/24
16:35
05/24/19
16:35
Syndicate
Breaking Syndicate news story on Toronto-Dominion »

Toronto-Dominion files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
05/24/19
05/24
16:30
05/24/19
16:30
Options
Preliminary option volume of 15.7M today »

Preliminary option volume…

CBUS

Cibus

$0.00

(0.00%)

16:25
05/24/19
05/24
16:25
05/24/19
16:25
Syndicate
Cibus requests withdrawal of registration statement »

The company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$355.14

4.57 (1.30%)

16:23
05/24/19
05/24
16:23
05/24/19
16:23
Periodicals
Boeing 737 MAX return delayed by FAA expanding review, WSJ reports »

A review of Boeing's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

FB

Facebook

$181.03

0.14 (0.08%)

, BA

Boeing

$355.14

4.57 (1.30%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
On The Fly
Fly Intel: Wall Street's top stories for Friday »

U.S. stocks, which had a…

FB

Facebook

$181.03

0.14 (0.08%)

BA

Boeing

$355.14

4.57 (1.30%)

UAL

United Continental

$80.77

-0.14 (-0.17%)

SMI

SMIC

$5.23

-0.26 (-4.74%)

HPQ

HP Inc.

$20.03

0.835 (4.35%)

HPE

HP Enterprise

$14.36

0.03 (0.21%)

NVS

Novartis

$87.49

3.03 (3.59%)

CNC

Centene

$56.84

1.39 (2.51%)

WCG

WellCare

$275.45

0.99 (0.36%)

TSS

TSYS

$113.42

13.81 (13.86%)

GPN

Global Payments

$153.42

5.45 (3.68%)

HIBB

Hibbett Sports

$23.91

4.07 (20.51%)

DVAX

Dynavax

$5.77

-0.59 (-9.28%)

FL

Foot Locker

$44.39

-8.455 (-16.00%)

SPLK

Splunk

$119.13

-9.55 (-7.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 09

    Jun

  • 10

    Jun

  • 13

    Jun

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 09

    Jul

  • 09

    Jul

  • 23

    Jul

  • 13

    Nov

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
Options
Closing CBOE SPX and VIX Index summary for May 24th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
05/24/19
05/24
16:17
05/24/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
05/24/19
05/24
16:16
05/24/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHE

Regional Health Properties

$2.06

0.09 (4.57%)

16:15
05/24/19
05/24
16:15
05/24/19
16:15
Hot Stocks
Regional Health Properties receives NYSE notice over late Form 10-Q filing »

Regional Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBIO

Translate Bio

$9.12

-0.09 (-0.98%)

16:14
05/24/19
05/24
16:14
05/24/19
16:14
Syndicate
Breaking Syndicate news story on Translate Bio »

Translate Bio files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.